$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
达沙替尼的服用剂量是多少
2025-10-19 11:44:20
Check Details
达沙替尼剂量增加需要什么条件
2025-10-19 11:44:20
Check Details
达沙替尼服用过量怎么办
2025-10-19 11:44:20
Check Details
达沙替尼在肝、肾损伤的患者中需要修改剂量吗?
2025-10-19 11:44:20
Check Details
普纳替尼(Ponatinib)说明书
2025-10-19 11:44:20
Check Details
服用达沙替尼QT间期如何变化
2025-10-19 11:44:20
Check Details
达沙替尼的药效能维持多久
2025-10-19 11:44:20
Check Details
达沙替尼服用期间的注意事项
2025-10-19 11:44:20
Check Details
达沙替尼的疗效分析
2025-10-19 11:44:20
Check Details
达沙替尼对白血病有没有作用
2025-10-19 11:44:20
Check Details
达沙替尼服用过量之后有什么需要注意的地方
2025-10-19 11:44:20
Check Details
达沙替尼在具有局部器官损伤时如何调整剂量?
2025-10-19 11:44:20
Check Details
1
2
...
4413
4414
4415
4416
4417
4418
4419
...
10208
10209
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Avatrombopag vs Hetrombopag: Full Comparison of TPO Receptor Agonists for Thrombocytopenia
2
Deucravacitinib (Sotyktu): TYK2 Inhibitor Guide for Plaque Psoriasis Treatment
3
Biktarvy (Bictegravir/Emtricitabine/TAF) Dosing & Food Administration Guide
4
Valganciclovir (Valcyte) CMV Infection: Dosing Duration & Management Guide
5
Cabergoline Dosing Guide: Hyperprolactinemia & Prolactin Level Regulation
6
Rucaparib (Rubraca): Full FDA-Approved Guide for BRCA-Mutated Prostate Cancer Treatment
7
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
8
Aspirin Enteric-Coated Tablets: Guide for Cardiovascular and Cerebrovascular Thrombosis Prevention
9
Comprehensive Analysis of the Third-Generation EGFR-TKI
10
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
11
Kresladi Approved by FDA: First Gene Therapy for Severe LAD-I
12
From Causes to Treatments—Exploring Medical Breakthroughs